Meet The TP3AG Team
The P3 Acceleration Group (TP3AG) is a group of experienced executives whose careers have been focused on taking innovative ideas to market by strategically navigating the buildout of best-in-class life science and diagnostic organizations. This experience makes us uniquely equipped to be involved in all aspects of your due diligence on new or existing investments including business analysis, industry thesis, competitive landscape, business/pricing model, and financial modeling as it relates to validation of the assumptions in the model to determine the return expectations.
TP3AG Founders & Partners
Sally Bowden
BJ Kerns
Sally has over 30 years of experience in the quality, regulatory and operations field in medical devices, companion diagnostics, education, and health care systems. She has extensive executive experience in establishing the quality and regulatory path forward for numerous successful companies. She has also served as Associate Professor of Engineering and Technology at Purdue University.
BJ has over 30 years of executive leadership in marketing, sales and operations in the life science and diagnostic industries. She has extensive experience in assessing and developing business plans and growth strategies that include business analysis, industry thesis, competitive landscape, product/pricing models, and financial modeling. She has assisted in private and public capital fundraises including the IPO for HTG, Inc.
TP3AG Advisors
TJ Johnson
TJ is an accomplished CEO and well-rounded executive with more than 30 years of experience in medical devices, research tools and diagnostics. He has extensive experience in strategy development & deployment, corporate development, private & public capital raise, building teams and driving growth via portfolio/product development, commercialization excellence and stewarding high performance cultures.
TP3AG Junior Partners
John Luecke
John has over 20 years of commercial, technical, and strategy experience in a variety of entrepreneurial settings. These experiences provide a unique perspective into commercializing novel, disruptive technologies.
TP3AG Associates
Barbara Glazer
Sue Pierce
Barbara has enjoyed a career of over 30 years focused on clinical laboratory and biobanking management and operations. Starting at Quintiles, Barbara rose through positions in project management before leading a team of 80 associates as Director of Pre-Analytical Services. She then served as VP, Compliance and Clinical Trials at a growing genomics laboratory. More recently Barbara has supported CAP / CLIA accreditation and QMS efforts for multiple clients.
Sue has over 30 years of experience leading multidisciplinary teams in developing medical diagnostic products. She is an executive leader that ensures new products will meet user needs while balancing the business needs. Sue is skilled in project and portfolio management, system integration, technical support as well as practical implementation of FDA Design Controls and CLIA Lab validations.
Cory Coddington
James Bowers II
Boasting over three decades in IT design and robust cybersecurity, Cory has successfully overseen assets amounting to $1.7 billion. Serving as a Virtual CTO and CISO, his vast expertise encompasses not only advanced networking and stringent ISO27001 compliance but also delves into the pioneering realm of machine learning and AI, positioning him at the forefront of technological innovation.
Identifying (and planning for) risk prevents catastrophe. Finding opportunity within those risks transforms markets. As an entrepreneur with over 20 years of risk analysis and management experience, James has an uncommonly pragmatic and easy to understand approach to managing risk, compliance, and cybersecurity. He has supported multinational financial and healthcare organizations and even had his skills put to the test at NASA.
Cynthia Pointer
Cynthia Pointer is a market access executive with over 25 years of experience. Her expertise includes global reimbursement, health policy, government affairs, and CMS account management. Prior to her consulting career, Cynthia served in major leadership positions in both the pharmaceutical and diagnostic space including roles with Akili, Genapsys, ArcherDX, Invitae, Genzyme, Regeneron, and Millennium.
TP3AG Founders & Partners
Sally has over 30 years of experience in the quality, regulatory and operations field in medical devices, companion diagnostics, education, and health care systems. She has extensive executive experience in establishing the quality and regulatory path forward for numerous successful companies. She has also served as Associate Professor of Engineering and Technology at Purdue University.
BJ has over 30 years of executive leadership in marketing, sales and operations in the life science and diagnostic industries. She has extensive experience in assessing and developing business plans and growth strategies that include business analysis, industry thesis, competitive landscape, product/pricing models, and financial modeling. She has assisted in private and public capital fundraises including the IPO for HTG, Inc.
TP3AG Advisors
TJ Johnson
TJ is an accomplished CEO and well-rounded executive with more than 30 years of experience in medical devices, research tools and diagnostics. He has extensive experience in strategy development & deployment, corporate development, private & public capital raise, building teams and driving growth via portfolio/product development, commercialization excellence and stewarding high performance cultures.
TP3AG Junior Partners
John Luecke
John has over 20 years of commercial, technical, and strategy experience in a variety of entrepreneurial settings. These experiences provide a unique perspective into commercializing novel, disruptive technologies.
TP3AG Associates
Barbara Glazer
Barbara has enjoyed a career of over 30 years focused on clinical laboratory and biobanking management and operations. Starting at Quintiles, Barbara rose through positions in project management before leading a team of 80 associates as Director of Pre-Analytical Services. She then served as VP, Compliance and Clinical Trials at a growing genomics laboratory. More recently Barbara has supported CAP / CLIA accreditation and QMS efforts for multiple clients.
Sue Pierce
Sue has over 30 years of experience leading multidisciplinary teams in developing medical diagnostic products. She is an executive leader that ensures new products will meet user needs while balancing the business needs. Sue is skilled in project and portfolio management, system integration, technical support as well as practical implementation of FDA Design Controls and CLIA Lab validations.
Cory Coddington
Boasting over three decades in IT design and robust cybersecurity, Cory has successfully overseen assets amounting to $1.7 billion. Serving as a Virtual CTO and CISO, his vast expertise encompasses not only advanced networking and stringent ISO27001 compliance but also delves into the pioneering realm of machine learning and AI, positioning him at the forefront of technological innovation.
James Bowers II
Identifying (and planning for) risk prevents catastrophe. Finding opportunity within those risks transforms markets. As an entrepreneur with over 20 years of risk analysis and management experience, James has an uncommonly pragmatic and easy to understand approach to managing risk, compliance, and cybersecurity. He has supported multinational financial and healthcare organizations and even had his skills put to the test at NASA.
Cynthia Pointer
Cynthia Pointer is a market access executive with over 25 years of experience. Her expertise includes global reimbursement, health policy, government affairs, and CMS account management. Prior to her consulting career, Cynthia served in major leadership positions in both the pharmaceutical and diagnostic space including roles with Akili, Genapsys, ArcherDX, Invitae, Genzyme, Regeneron, and Millennium.